ATRA 241220 0.50P (ATRA241220P500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

ATRA241220P500

Watchlist

0.00
0.000.00%

15min DelayClose Dec 20 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Atara Biotherapeutics Analyst Ratings
BenzingaDec 20 07:59 ET · Ratings
Rodman & Renshaw Initiates Coverage on Atara Biotherapeutics With Buy Rating, $25 Price Target
MT NewswiresDec 20 07:12 ET · Ratings
Kyverna Therapeutics Picks Former Atara Bio, Kite Executives for Leadership Roles
MT NewswiresDec 13 16:50 ET
Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of Hematology Annual Meeting Confirm Efficacy, Safety and Durability of Novel Allogeneic Cell Therapy Tabelecleucel in Relapsed or Refractory Epstein-Barr Virus Positive...
PR NewswireDec 7 12:33 ET
Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference
BusinesswireNov 27 16:01 ET
Insider Sale: EVP of $ATRA (ATRA) Sells 1,000 Shares
Quiver QuantitativeNov 20 18:16 ET

Comments

Stock_Drift

Dec 10 17:09

After Hours Ticks. 5:08pm

$BIOSIG TECHNOLOGIES INC (BSGM.US)$ $Atara Biotherapeutics (ATRA.US)$ $SEALSQ Corp (LAES.US)$ $iHeartMedia (IHRT.US)$ $KORE Group (KORE.US)$ $Verb Technology (VERB.US)$ $MIND Technology (MIND.US)$ $SFIX (SFIX.CA)$ $VolitionRX (VNRX.US)$ $Anghami (ANGH.US)$ $Frequency Electronics (FEIM.US)$ $Bleichroeder Acquisition Corp. I (BACQ.US)$ $CleanCore Solutions (ZONE.US)$
📊⚡️📊

Jaguar8

Dec 8 18:20

NEWS SATURDAY

$Atara Biotherapeutics (ATRA.US)$
Updated Clinical Results: ALLELE study, a pivotal Phase 3 clinical trial evaluating tabelecleucel (tab-cel) in patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) after failure of rituximab or rituximab and chemotherapy.
The study demonstrated a statistically significant overall response rate (ORR) of 49%, with a median duration of response of 23 months ano nedian overall survival of 18.4 months. The sa...

Stock_Drift

Nov 15 16:17

After Hours Ticks. 5:16pm 11/15🦌

$Scorpius Holdings (SCPX.US)$ $Perspective Therapeutics (CATX.US)$ $Turbo Energy (TURB.US)$ $Adverum Biotechnologies (ADVM.US)$ $NFT Ltd (MI.US)$ $Xylo Technologies (XYLO.US)$ $Lipocine (LPCN.US)$ $Massimo (MAMO.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Edesa Biotech (EDSA.US)$ $Atara Biotherapeutics (ATRA.US)$ $Eterna Therapeutics (ERNA.US)$ $DDC Enterprise (DDC.US)$
📊⚡️📊

joeyboulevard

Nov 5 07:16

$Atara Biotherapeutics (ATRA.US)$ Looks good!

Jaguar8

Sep 5 15:19

Atara Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adiumentum Capital Fund I LP(19.99%),Adiumentum Capital Fund I GP LLC(19.99%), etc.

$Atara Biotherapeutics (ATRA.US)$